Sarah Elizabeth Richards, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Sat, 14 Oct 2023 03:07:42 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Sarah Elizabeth Richards, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Research Shows Long-Term Benefit for Adjuvant Targeted Therapies in High-Risk Melanoma https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/melanoma-braf-treatment-risk-dabrafenib-trametinib/ Wed, 28 Oct 2020 14:00:09 +0000 https://www.oncologynurseadvisor.com/?p=86042 More than half of patients with resected stage 3 melanoma with BRAF V600E or V600K mutations receiving a year’s worth of adjuvant dabrafenib and trametinib were still alive 5 years later.More than half of patients with resected stage 3 melanoma with BRAF V600E or V600K mutations receiving a year’s worth of adjuvant dabrafenib and trametinib were still alive 5 years later.]]> Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/covid19-coronavirus-cancer-researchers-crowdsourcing-learn-more/ Mon, 11 May 2020 16:00:23 +0000 https://www.cancertherapyadvisor.com/?p=87854 Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.Pooling data from physicians and patients appears to be an efficient way to answer urgent questions.]]> New Research Says There’s No Significant Link Between Talc and Ovarian Cancer, but Some Scientists Push Back Against the Study’s Data and Design https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/talcum-powder-ovarian-cancer-research-link-study-design-data/ Wed, 08 Jan 2020 15:12:33 +0000 https://www.cancertherapyadvisor.com/?p=78488 Some experts say the talc study’s data limitations weaken its impact in the field.Some experts say the talc study’s data limitations weaken its impact in the field.]]> The Disappointing Reality of Crowdfunding Cancer Care https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/crowdfunding-cancer-care-cost-disappointing-reality/ Tue, 22 Oct 2019 13:00:38 +0000 https://www.oncologynurseadvisor.com/?p=68682 If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.]]> A Tool to Select Candidates for Allogeneic Hematopoietic Cell Transplant in CLL https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/chronic-leukemia-cll-tool-select-candidates-allogeneic-stem-cell-transplant/ Fri, 30 Aug 2019 17:38:03 +0000 https://www.oncologynurseadvisor.com/?p=66768 As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.]]>